Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer

Publisher： Karger

E-ISSN： 1662-6575|9|1|158-163

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.1, 2016-03, pp. : 158-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 51-55

Karger

Access to resources Recommend Favorite

Topotecan in the First-Line Treatment of Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Topotecan/Taxol in First-Line Small-Cell Lung Cancer: Where Is the Benefit?

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. : 7-8

Karger

Access to resources Recommend Favorite

First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 12, 2008-11 ,pp. : 665-670

Karger

Access to resources Recommend Favorite